Rosemary Extract Supplement Pharmacokinetic

Overview

About this study

The purpose of this study is to improve muscle health and metabolism in humans, a food product for humans that contains ursolic acid (CJ dietary supplement).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

- Healthy subjects aged between 25 and 55 years.

- Non-smoker.

- Body Mass Index (BMI) between 20 and 30 kg/m^2.

Exclusion Criteria:

- Any history or presence of cardiovascular, pulmonary, gastro-intestinal, hepatic, renal, endocrine, metabolic, hematological, neurologic, psychiatric, systemic or
infectious disease.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/7/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Ian Lanza, Ph.D.	Closed for enrollment	Contact information: Rose Decker (507) 255-6770 Bilderback.Rose@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ian Lanza, Ph.D.

Closed for enrollment

Contact information:

Rose Decker

(507) 255-6770

Bilderback.Rose@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials